|
Clinical and Laboratory Characteristics of a Population of Children and Adolescents With Newly Diagnosed Type 1 Diabetes and Insulin Requirements at Onset
RECRUITINGSponsored by IRCCS Azienda Ospedaliero-Universitaria di Bologna
Actively Recruiting
SponsorIRCCS Azienda Ospedaliero-Universitaria di Bologna
Started2020-10-09
Est. completion2024-12-31
Eligibility
Healthy vol.Accepted
View on ClinicalTrials.gov →
NCT06717893
Summary
The clinical implication of this study lies in the identification of factors that may predict reduced insulin sensitivity in children and adolescents at the onset of Type 1 Diabetes and would help the physician to undertake appropriate therapy more quickly by achieving the correct therapeutic dosage, in order to achieve good metabolic compensation at an early stage and thus reduce the time (and costs) of hospitalisation.
Eligibility
Healthy volunteers accepted
Inclusion Criteria: * Age ≤ 14 years at the time of diagnosis of type 1 diabetes; * Diagnosis of type 1 diabetes confirmed between January 2014 and December 2018 at the Pediatrics Unit of the IRCCS Azienda Ospedaliero-Universitaria of Bologna, Italy; * Patients with at least 1 year of follow-up after diagnosis od type 1 diabetes; * Obtaining informed consent from parents/legal guardian of pediatric patients. Exclusion Criteria: * Patients with diabetes other that type 1; * Patients followed at other centres at the time of onset of type 1 diabetes.
Conditions2
DiabetesType 1 Diabetes (T1D)
Browse More Trials
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.
Actively Recruiting
SponsorIRCCS Azienda Ospedaliero-Universitaria di Bologna
Started2020-10-09
Est. completion2024-12-31
Eligibility
Healthy vol.Accepted
View on ClinicalTrials.gov →
NCT06717893